|
HDAC3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.07744932367859E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.67643676718399E-14 |
| Normal-vs-Stage2 |
2.244100E-04 |
| Normal-vs-Stage3 |
5.21649999973839E-07 |
| Normal-vs-Stage4 |
2.05969999999001E-05 |
| Stage1-vs-Stage2 |
1.736200E-01 |
| Stage1-vs-Stage3 |
8.347800E-02 |
| Stage1-vs-Stage4 |
3.807900E-02 |
| Stage2-vs-Stage3 |
9.638800E-01 |
| Stage2-vs-Stage4 |
7.442800E-01 |
| Stage3-vs-Stage4 |
6.618800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.90194559890733E-13 |
| Normal-vs-AfricanAmerican |
1.035050E-03 |
| Normal-vs-Asian |
3.726300E-02 |
| Caucasian-vs-AfricanAmerican |
2.858000E-01 |
| Caucasian-vs-Asian |
4.377000E-01 |
| AfricanAmerican-vs-Asian |
2.947400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.57112125928916E-12 |
| Normal-vs-Female |
3.84470233427692E-11 |
| Male-vs-Female |
9.214600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.340400E-02 |
| Normal-vs-Age(41-60Yrs) |
2.1925017357205E-11 |
| Normal-vs-Age(61-80Yrs) |
6.24877927180023E-12 |
| Normal-vs-Age(81-100Yrs) |
2.884300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.623650E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.375550E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.746350E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.138000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.450400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.087600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.640300E-03 |
| Normal-vs-Grade 2 |
2.81885625952327E-13 |
| Normal-vs-Grade 3 |
4.00900423969119E-11 |
| Normal-vs-Grade 4 |
6.357200E-04 |
| Grade 1-vs-Grade 2 |
5.999800E-01 |
| Grade 1-vs-Grade 3 |
5.465400E-01 |
| Grade 1-vs-Grade 4 |
1.348050E-01 |
| Grade 2-vs-Grade 3 |
6.816000E-01 |
| Grade 2-vs-Grade 4 |
2.050400E-02 |
| Grade 3-vs-Grade 4 |
6.946200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62447832963153E-12 |
| Normal-vs-ccB subtype |
1.53249000000022E-05 |
| ccA subtype-vs-ccB subtype |
6.23869999999416E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.78229669806274E-11 |
| Normal-vs-N1 |
6.192300E-02 |
| N0-vs-N1 |
6.497600E-01 |
|
|
